ZENI: Q2 2024 saw record Q2 revenue, positive operating profit, and strengthened liquidity

About this update from Zenicor Medical Systems Ab

Q2 2024 revenue grew 3% year-over-year to 6,430 KSEK, with positive operating profit and improved EBITDA. Liquidity was strengthened by new loans, and a 20% growth rate is targeted by year-end. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Zenicor Medical Systems Ab